Acute tubular necrosis due to captopril

被引:8
作者
Al Shohaib, S [1 ]
Raweily, E
机构
[1] King Khalid Natl Guard Hosp, Dept Med, Jeddah 21423, Saudi Arabia
[2] King Khalid Natl Guard Hosp, Dept Pathol, Jeddah 21423, Saudi Arabia
关键词
angiotensin-converting enzyme inhibitors captopril; congestive heart failure; acute renal failure;
D O I
10.1159/000013573
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-converting enzyme (ACE) inhibitors are standard therapy for congestive cardiac failure. ACE inhibitors have been used worldwide and are usually safe and have relatively few side effects. Hypotension can develop with the first dose of captopril and can lead to symptomatic renal hypoperfusion with subsequent acute renal failure (ARF), The case of a 65-year-old patient with congestive heart failure who developed acute renal failure following the first dose of captopril is described. He required hemodialysis for 8 weeks for the improvement of his renal function and urinary output. The renal biopsy confirmed the presence of acute tubular necrosis, The reversibility of captopril-induced ARF is confirmed and the patient made an uneventful recovery. An immunoallergic mechanism is not thought to have been responsible for this adverse effect. It is advised that caution should be exerted in giving ACE inhibitors to elderly patients with congestive heart failure, particularly if they are on diuretics. Routine biochemical monitoring is suggested before and during captopril therapy. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:149 / 152
页数:4
相关论文
共 17 条
[1]   REVERSIBLE RENAL-FAILURE DUE TO THE USE OF CAPTOPRIL IN A RENAL-ALLOGRAFT RECIPIENT TREATED WITH CYCLOSPORINE [J].
AHMAD, T ;
COULTHARD, MG ;
EASTHAM, EJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (04) :311-312
[2]  
DURAND D, 1986, ARCH MAL COEUR VAISS, V79, P888
[3]   REVERSIBLE ACUTE INTERSTITIAL GRANULOMATOUS NEPHRITIS AFTER TREATMENT WITH CAPTOPRIL [J].
ISLAM, S ;
DUBIGEON, MP ;
GUENEL, J .
REVUE DE MEDECINE INTERNE, 1990, 11 (03) :231-233
[4]  
LoghmanAdham M, 1997, CLIN NEPHROL, V47, P76
[5]  
MCEVOY GK, 1997, DRUG INFORMATION, P1218
[6]  
NICKLAS JM, 1992, NEW ENGL J MED, V327, P685
[8]  
OPIE LH, 1995, AM J CARDIOL, V75, P3
[9]  
PARKER M, 1986, POSTGRAD MED J S1, V62, P179
[10]   EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL [J].
PFEFFER, MA ;
BRAUNWALD, E ;
MOYE, LA ;
BASTA, L ;
BROWN, EJ ;
CUDDY, TE ;
DAVIS, BR ;
GELTMAN, EM ;
GOLDMAN, S ;
FLAKER, GC ;
KLEIN, M ;
LAMAS, GA ;
PACKER, M ;
ROULEAU, J ;
ROULEAU, JL ;
RUTHERFORD, J ;
WERTHEIMER, JH ;
HAWKINS, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) :669-677